TrialBMJ open2018

Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3).

Rahat A Abdoellakhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.